Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00743236 · ClinicalTrials.gov registry record · NA

Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT00743236 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00743236, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

RATIONALE: Warm ischemia is the clamping of blood vessels without cooling the kidney. Cold ischemia is the clamping of blood vessels with kidney cooling. It is not yet known whether warm ischemia is more effective than cold ischemia in patients undergoing surgery for stage I kidney cancer. PURPOSE: This randomized phase III trial is studying warm ischemia to see how well it works compared with cold ischemia during surgery in treating patients with stage I kidney cancer.

Interventions

  • PROCEDURE cold ischemia procedure
  • PROCEDURE warm ischemia procedure

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2008-08
Est. Completion 2009-06
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT00743236

The ClinicalTrials.gov registry entry for NCT00743236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which cold ischemia procedure is the first listed.

NCT00743236 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00743236 about?

NCT00743236 is a clinical study titled "Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer". RATIONALE: Warm ischemia is the clamping of blood vessels without cooling the kidney. Cold ischemia is the clamping of blood vessels with kidney cooling. It is not yet known whether warm ischemia is more effective than cold ischemia in patients undergoing surgery for stage I kidney cancer. PURPOSE:...

What is the current status of trial NCT00743236?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2008-08. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00743236?

The interventions under investigation include: cold ischemia procedure (PROCEDURE), warm ischemia procedure (PROCEDURE).

Who is sponsoring clinical trial NCT00743236?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.